Top 10 Companies in the (R)-1-(3-Chlorophenyl)-ethylamine (CAS 17061-53-9) Market (2026): Market Leaders Powering Global Pharma

MARKET INSIGHTS

Global (R)-1-(3-Chlorophenyl)-ethylamine (CAS 17061-53-9) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(R)-1-(3-Chlorophenyl)-ethylamine is a chiral amine compound bearing a single stereocenter, characterized by its (R)-configuration at the alpha carbon. It serves as a highly valuable building block and chiral intermediate in the synthesis of pharmaceutically active molecules, agrochemicals, and fine chemicals. The compound’s enantiopure nature makes it particularly sought after in asymmetric synthesis, where stereochemical precision is critical to the biological activity and safety profile of the end product.

The market is witnessing steady growth driven by rising demand for chiral intermediates in pharmaceutical manufacturing, particularly in the development of central nervous system (CNS) drugs and selective receptor modulators. Furthermore, the increasing adoption of green chemistry principles and biocatalytic resolution techniques is improving production efficiency and yield purity. Key suppliers operating in this space include Sigma-Aldrich (Merck KGaA), TCI Chemicals, and Thermo Fisher Scientific, among other fine chemical manufacturers with established chiral synthesis capabilities.

(R)-1-(3-Chlorophenyl)-ethylamine (CAS 17061-53-9) Market – View in Detailed Research Report

---

🔟 1. Pharmablock Sciences Inc.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical‑grade (R)-1-(3‑Chlorophenyl)-ethylamine, high‑purity (>99% ee)

Pharmablock Sciences specializes in large‑scale asymmetric hydrogenation and enzymatic resolution, delivering consistent enantiomeric excess for API development. Their integrated R&D and production facilities enable rapid scale‑up for emerging CNS therapeutics.

Sustainability Initiatives:

• Investment in low‑energy, high‑yield hydrogenation catalysts
• Closed‑loop solvent recycling program
• Carbon‑neutral production target by 2035

---

🔟 2. Capot Chemical Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: Ultra‑high purity (≥99.5% ee) chiral intermediates for CNS and oncology APIs

Capot leverages proprietary chiral catalysts and scalable biocatalytic processes, ensuring regulatory compliance with cGMP and ICH impurity limits.

Sustainability Initiatives:

• Biocatalytic resolution reduces hazardous waste by 40%
• Renewable energy integration in manufacturing plants
• Green chemistry advisory services for clients

---

🔟 3. Finetech Industry Limited

Headquarters: Shenzhen, China
Key Offering: Technical‑grade chiral amines for agrochemical synthesis

Finetech focuses on cost‑effective, high‑throughput production using asymmetric reduction, catering to the growing demand for enantiomerically pure agrochemicals.

Sustainability Initiatives:

• Waste‑to‑energy conversion for process heat
• Effluent treatment to meet strict EPA standards
• Partnerships with NGOs for sustainable agriculture

---

🔟 4. Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Research‑grade chiral intermediates for academic and industrial R&D

Enamine provides customizable synthesis routes and rapid turnaround, supporting academic institutions and contract research organizations.

Sustainability Initiatives:

• Implementation of green chemistry protocols in all labs
• Carbon offset program for international shipments
• Support for sustainable research projects

---

🔟 5. Hairui Chemicals Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Reagent‑grade (R)-1-(3‑Chlorophenyl)-ethylamine for fine‑chemical synthesis

Hairui offers high‑purity reagents at competitive pricing, facilitating process development for new APIs and specialty chemicals.

Sustainability Initiatives:

• Energy‑efficient manufacturing units
• Zero‑liquid‑discharge policy
• Community outreach on chemical safety

---

🔟 6. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: Technical‑grade chiral amines with advanced purity controls

TCI integrates cutting‑edge chiral resolution technologies to deliver consistent enantiomeric excess for pharmaceutical intermediates.

Sustainability Initiatives:

• Adoption of renewable energy sources in production
• Closed‑loop solvent recovery system
• Compliance with REACH and Japan’s chemicals management regulations

---

🔟 7. Boc Sciences

Headquarters: New York, United States
Key Offering: Custom synthesis of (R)-1-(3‑Chlorophenyl)-ethylamine for API development

Boc Sciences provides flexible, small‑batch production tailored to early‑stage R&D and pilot‑scale manufacturing.

Sustainability Initiatives:

• Green chemistry consulting services
• Waste minimization through process optimization
• Carbon‑neutral shipping options

---

🔟 8. Oakwood Products, Inc.

Headquarters: Milwaukee, United States
Key Offering: Pharmaceutical‑grade chiral intermediates with GMP certification

Oakwood delivers high‑quality chiral amines with robust traceability and batch consistency for regulated markets.

Sustainability Initiatives:

• Implementation of ISO 14001 environmental management
• Energy‑efficient HVAC systems
• Supplier sustainability assessment program

---

🔟 9. Chem‑Impex International, Inc.

Headquarters: Los Angeles, United States
Key Offering: Reagent‑grade (R)-1-(3‑Chlorophenyl)-ethylamine for academic and industrial use

Chem‑Impex focuses on rapid delivery and technical support for research laboratories and small‑scale manufacturers.

Sustainability Initiatives:

• Eco‑friendly packaging solutions
• Carbon footprint reduction program
• Partnerships with local recycling initiatives

---

🔟 10. Biosynth AG

Headquarters: Basel, Switzerland
Key Offering: Ultra‑high purity (≥99.5% ee) chiral intermediates for clinical‑grade APIs

Biosynth specializes in scalable, sustainable synthesis routes, supporting late‑stage development and commercial production.

Sustainability Initiatives:

• Renewable energy sourcing for all plants
• Zero‑waste manufacturing commitment
• Investment in green catalyst research

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307491/ethylamine-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307491/ethylamine-market

---

🌍 Outlook: The Future of (R)-1-(3-Chlorophenyl)-ethylamine is Cleaner and Smarter

The (R)-1-(3‑Chlorophenyl)-ethylamine market is poised for dynamic growth, driven by the expansion of CNS drug pipelines, the push for chiral purity, and the adoption of sustainable manufacturing practices. As regulatory frameworks tighten and global demand for enantiomerically pure APIs rises, suppliers are investing in advanced biocatalytic processes, renewable energy integration, and digital supply chain solutions to meet evolving expectations.

📈 Key Trends Shaping the Market:

• Accelerated deployment of asymmetric biocatalysis, reducing waste by up to 40%
• Growth of regional manufacturing hubs in Asia‑Pacific and Latin America to meet local API demand
• Increased regulatory focus on chiral impurity profiling, driving higher purity standards
• Strategic partnerships between fine‑chemical producers and API manufacturers to secure supply chains
• Emergence of green chemistry initiatives, positioning premium, eco‑friendly grades at a 10‑15% price premium